Galmed pharmaceuticals Contact Number

All Time Past 24 Hours Past Week Past month Post Your Comments?

About Galmed pharmaceuticals Contact Number

Contact Email [email protected] Phone Number +972 3-693-8448 Galmed Pharmaceuticals Ltd. is a clinical stage drug development biopharmaceutical company for liver, metabolic and inflammatory diseases. Our lead compound, Aramchol™, a backbone drug candidate for the treatment of NASH and fibrosis is currently in a Phase 3 registrational study.

Contact US: https://www.crunchbase.com/organization/galmed-pharmaceuticals

Galmed

42 People Used

See More ››

Galmed Pharmaceuticals

Galmed Pharmaceuticals to Report Fourth Quarter and Year End 2020 Financial Results and Provide Business Update on Thursday March 18. Feb 16, 2021. Galmed Pharmaceuticals Announces Pricing of $10 Million Public Offering of Ordinary Shares. Feb 16, 2021.

View Contact ››

GALMED

123 People Used

See More ››

GALMED PHARMACEUTICALS LTD Company Profile TEL AVIV

GALMED PHARMACEUTICALS LTD is located in TEL AVIV-JAFFA, Israel and is part of the Scientific Research & Development Services Industry. GALMED PHARMACEUTICALS LTD has 20 employees at this location and generates $1.49 million in sales (USD). There are 3 companies in the GALMED PHARMACEUTICALS LTD corporate family.

View Contact ››

Privately

45 People Used

See More ››

Company Profile

Galmed’s business has been operating since 2000 under a different group of companies estab­lished in the same year. Galmed Pharmaceuticals Ltd. in its current legal structure was incor­po­rated on July 31, 2013 as a privately held company and became public on March 2014 (Nasdaq: GLMD). Company Profile. Leadership. Board of Directors.

View Contact ››

Executive

41 People Used

See More ››

Leadership

Mr. Baharaff is the co- founder of Galmed, and has served as CEO since 2012, and President as of 2015. Previously, he held a number of senior executive positions, including SVP at Isramex Projects Ltd., and Managing Director of T+M Trusteeship & Management.

View Contact ››

Galmed

69 People Used

See More ››

Galmed Pharmaceuticals

Galmed Pharmaceuticals Announces Pricing of $10 Million Public Offering of Ordinary Shares TEL AVIV, Israel, Feb. 16, 2021 /PRNewswire/ -- Galmed Pharmaceuticals Ltd. (Nasdaq: GLMD) ("Galmed" or the "Company"), a clinical-stage biopharmaceutical company for liver, metabolic and inflammatory diseases, today announced the pricing of the underwritten public offering of 2,197,803

View Contact ››

Repackaging

45 People Used

See More ››

Contacts GALMED

Contact and Directors office. Galmed a.s. Slánská 79, Brandýsek, 273 41 Phone: +420 312 777 052, 312 777 054 Fax: +420 312 777 013 E-mail: [email protected]galmed.cz Production and repackaging office

View Contact ››

Company

57 People Used

See More ››

Galmed Pharmaceuticals Ltd

Company profile page for Galmed Pharmaceuticals Ltd including stock price, company news, press releases, executives, board members, and contact information

View Contact ››

Percent

77 People Used

See More ››

Galmed Pharmaceuticals Ltd

Galmed Pharmaceuticals Ltd. March 9, 2017 ·. #fructose consumption linked to #NAFLD. Non-alcoholic fatty liver disease is a condition that currently affects up to 25 percent of the American population. Among the factors contributing to this disease, weight, exercising, and diet are some of the most important.

View Contact ››

Please leave your comments here:

Popular Brands

Gbl
Gevo
Gic
Godrej
Geely
Graco
Gpa